The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing
Open accessAbstract
Oral antibiotics such as metronidazole, vancomycin and fidaxomicin are therapies of choice for Clostridium difficile infection. Several important mechanisms for C. difficile antibiotic resistance have been described, including the acquisition of antibiotic resistance genes via the transfer of mobile genetic elements, selective pressure in vivo resulting in gene mutations, altered expression of redox-active proteins, iron metabolism, and DNA repair, as well as via biofilm formation. This update summarizes new information published since 2010 on phenotypic and genotypic resistance mechanisms in C. difficile and addresses susceptibility test methods and other strategies to counter antibiotic resistance of C. difficile .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Emergence and global spread of epidemic healthcare-associated Clostridium difficile
He, M., Miyajima, F., Roberts, P., Ellison, L., Pickard, D. J., Martin, M. J., Connor, T. R., Harris, S. R., Fairley, D., Bamford, K. B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2478 · Cited by 735
Self-citationSlimings, C., & Riley, T. V. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt477 · Cited by 581
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
Diagnosis and Treatment of Clostridium difficile in Adults: A Systematic Review
Bagdasarian, N., Rao, K., & Malani, P. N. (2015) · JAMA · doi:10.1001/jama.2014.17103 · Cited by 451
Manual of Clinical Microbiology
(2015) · ASM Press eBooks · doi:10.1128/9781555817381 · Cited by 417
Bauer, M. P., Kuijper, E. J., & van Dissel, J. T. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03099.x · Cited by 366
Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing
Brook, I., Wexler, H. M., & Goldstein, E. J. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00086-12 · Cited by 333
Hrabák, J., Chudáčková, E., & Walková, R. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-12 · Cited by 304
Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
Thapa, T., Leuzzi, R., Ng, Y. K., Baban, S. T., Adamo, R., Kuehne, S. A., Scarselli, M., Minton, N. P., Serruto, D., & Unnikrishnan, M. (2013) · Journal of Bacteriology · doi:10.1128/jb.01980-12 · Cited by 291
Freeman, J., Vernon, J., Morris, K., Nicholson, S., Todhunter, S., Longshaw, C., & Wilcox, M. H. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.09.017 · Cited by 279
Shen, J., Wang, Y., & Schwarz, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt092 · Cited by 258
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection
Spigaglia, P. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115622891 · Cited by 254
Emergence of reduced susceptibility to metronidazole in Clostridium difficile
Baines, S. D., O'Connor, R., Freeman, J., Fawley, W. N., Harmanus, C., Mastrantonio, P., Kuijper, E. J., & Wilcox, M. H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn313 · Cited by 247
The economic burden of Clostridium difficile
McGlone, S. M., Bailey, R. R., Zimmer, S. M., Popovich, M. J., Tian, Y., Ufberg, P., Muder, R. R., & Lee, B. Y. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03571.x · Cited by 206
Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
O'Connor, J. R., Galang, M. A., Sambol, S. P., Hecht, D. W., Vedantam, G., Gerding, D. N., & Johnson, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-08 · Cited by 187
Evolutionary History of the Clostridium difficile Pathogenicity Locus
Dingle, K. E., Elliott, B., Robinson, E., Griffiths, D., Eyre, D. W., Stoesser, N., Vaughan, A., Golubchik, T., Fawley, W. N., Wilcox, M. H., et al. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evt204 · Cited by 185
Multidrug resistance in European Clostridium difficile clinical isolates
Spigaglia, P., Barbanti, F., Mastrantonio, P., on behalf of the European Study Group on Clostridium difficile (ESGCD), Ackermann, G., Balmelli, C., Barbut, F., Bouza, E., Brazier, J., Delmee, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr292 · Cited by 183
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
Kwon, J. H., Olsen, M. A., & Dubberke, E. R. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.003 · Cited by 178
Potential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
Linkevicius, M., Sandegren, L., & Andersson, D. I. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02465-15 · Cited by 165
Metronidazole Resistance in Clostridium difficile Is Heterogeneous
Peláez, T., Cercenado, E., Alcalá, L., Marín, M., Martín, A., Martínez-Alarcón, J., Catalán, P., Sánchez-Somolinos, M., & Bouza, E. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00524-08 · Cited by 156
Freeman, J., Baines, S. D., Jabes, D. L., & Wilcox, M. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki321 · Cited by 149
Johanesen, P., Mackin, K. E., Hutton, M. L., Awad, M. M., Larcombe, S., Amy, J., & Lyras, D. (2015) · Genes · doi:10.3390/genes6041347 · Cited by 130
Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China
Jin, D., Luo, Y., Huang, C., Cai, J., Ye, J., Zheng, Y. F., Wang, L., Zhao, P., Liu, A., Fang, W. J., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01898-16 · Cited by 126
Self-citationClostridium difficile infection: a review of current and emerging therapies
Ofosu, A. (2016) · Annals of Gastroenterology · doi:10.20524/aog.2016.0006 · Cited by 115
Brouwer, M. S. M., Warburton, P., Roberts, A. P., Mullany, P. P., & Allan, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023014 · Cited by 111
Leeds, J. A., Sachdeva, M., Mullin, S., Barnes, S. W., & Ruzin, A. V. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt302 · Cited by 97
Antimicrobial Susceptibility of Clostridium Difficile Clinical Isolates in Iran
Goudarzi, M., Goudarzi, H., Alebouyeh, M., Rad, M. A., Mehr, F. S. S., Zali, M. R., & Aslani, M. M. (2013) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.5189 · Cited by 92
Sun, X., & Hirota, S. A. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.09.005 · Cited by 91
Self-citationCharacterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate
Lynch, T., Chong, P. M., Zhang, J., Hizon, R., Du, T., Graham, M., Beniac, D. R., Booth, T. F., Kibsey, P., Miller, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053757 · Cited by 87
Baines, S. D., & Wilcox, M. H. (2015) · Antibiotics · doi:10.3390/antibiotics4030267 · Cited by 79
Reil, M., Erhard, M., Kuijper, E. J., Kist, M., Zaiss, H., Witte, W., Gruber, H., & Borgmann, S. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1238-6 · Cited by 72
Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole
Chong, P. M., Lynch, T., McCorrister, S. J., Kibsey, P., Miller, M., Gravel, D., Westmacott, G., Mulvey, M. R., & (CNISP), T. C. N. I. S. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082622 · Cited by 72
Snydman, D. R., McDermott, L. A., Jacobus, N. V., Thorpe, C. M., Stone, S., Jenkins, S. G., Goldstein, E. J. C., Patel, R., Forbes, B. A., Mirrett, S., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00845-15 · Cited by 70
Vuotto, C., Moura, I. B., Barbanti, F., Donelli, G., & Spigaglia, P. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv114 · Cited by 69
Pirš, T., Avberšek, J., Zdovc, I., Krt, B., Andlovic, A., Lejko-Zupanc, T., Rupnik, M., & Ocepek, M. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.058875-0 · Cited by 66
Wieczorkiewicz, J. T., Lopansri, B. K., Cheknis, A. K., Osmolski, J. R., Hecht, D. W., Gerding, D. N., & Johnson, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01820-15 · Cited by 63
Update on Clostridium difficile infection
O’Donoghue, C., & Kyne, L. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283411634 · Cited by 59
Fry, P. R., Thakur, S., Abley, M. J., & Gebreyes, W. A. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06581-11 · Cited by 50
Diagnosis and Treatment of Clostridium difficile Infection
Gupta, A., Cifu, A. S., & Khanna, S. (2018) · JAMA · doi:10.1001/jama.2018.12194 · Cited by 47
Spigaglia, P., Drigo, I., Barbanti, F., Mastrantonio, P., Bano, L., Bacchin, C., Puiatti, C., Tonon, E., Berto, G., & Agnoletti, F. (2014) · Anaerobe · doi:10.1016/j.anaerobe.2014.10.003 · Cited by 46
Moura, I. B., Monot, M., Tani, C., Spigaglia, P., Barbanti, F., Norais, N., Dupuy, B., Bouza, E., & Mastrantonio, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02350-14 · Cited by 43
Tsutsumi, L. S., Owusu, Y., Hurdle, J. G., & Sun, D. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026613666131113154753 · Cited by 42
Wasels, F., Monot, M., Spigaglia, P., Barbanti, F., Ma, L., Bouchier, C., Dupuy, B., & Mastrantonio, P. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0015 · Cited by 39
Lim, S., Foster, N. F., & Riley, T. V. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.12.004 · Cited by 34
Cadazolid: A new hope in the treatment of Clostridium difficile infection
Kali, A., Charles, M. V. P., & Srirangaraj, S. (2015) · Australasian Medical Journal · doi:10.4066/amj.2015.2441 · Cited by 32
Diagnosis and Treatment of Clostridium difficile Infection
Gerding, D. N., File, T. M., & McDonald, L. C. (2015) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000350 · Cited by 30
Rennie, R. P., Turnbull, L., Brosnikoff, C., & Cloke, J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05395-11 · Cited by 19
Cited by
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
In vivo commensal control of Clostridioides difficile virulence
Girinathan, B. P., DiBenedetto, N., Worley, J. N., Peltier, J., Arrieta-Ortiz, M. L., Immanuel, S. R. C., Lavin, R., Delaney, M. L., Cummins, C. K., Hoffman, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.007 · Cited by 114
Metadata
- Authors
- Peng, Z., Jin, D., Kim, H. B., Stratton, C. W., Wu, B., Tang, Y.-W., & Sun, X.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2017-07
- Volume
- 55
- Issue
- 7
- Pages
- 1998-2008
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2607392560
- Cited by
- 259
- References
- 52
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.